financetom
Business
financetom
/
Business
/
Accolade Agrees to be Acquired, Brought Private by Transcarent in $621 Million Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Accolade Agrees to be Acquired, Brought Private by Transcarent in $621 Million Deal
Jan 8, 2025 6:57 AM

09:21 AM EST, 01/08/2025 (MT Newswires) -- Accolade (ACCD) said Wednesday it has agreed to be acquired by Transcarent for $7.03 per share, which it said represents a total equity value of approximately $621 million.

The companies said the acquisition price represents a premium of approximately 110% over Accolade's Tuesday closing stock price.

The companies said Transcarent will finance the transaction through equity financing led by General Catalyst and Glen Tullman's 62 Ventures.

The boards of directors of both companies have unanimously approved the deal, which is expected to close in Q2 following stockholder and regulatory approvals and other customary closing conditions. Upon completion, Accolade will become a privately held company and its stock will no longer be listed on Nasdaq, the companies said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Samsung profit likely biggest in six quarters on higher chip prices
Samsung profit likely biggest in six quarters on higher chip prices
Apr 3, 2024
SEOUL (Reuters) - Samsung Electronics ( SSNLF ) is expected to post a near nine-fold increase in first-quarter profit from a year earlier as rebounding semiconductor prices lift earnings from a low base caused by a severe chip downturn. Operating profit for the world's biggest maker of memory chips and TVs likely rose to 5.7 trillion won ($4.24 billion) in...
MacroGenics Says Cancer Drug Study Update Set for May After Conference Miss
MacroGenics Says Cancer Drug Study Update Set for May After Conference Miss
Apr 3, 2024
05:46 PM EDT, 04/03/2024 (MT Newswires) -- MacroGenics ( MGNX ) said late Wednesday that interim safety data from the phase 2 trial of vobra duo in people with metastatic castration-resistant prostate cancer is set for end-May release after a company abstract wasn't accepted by the American Society of Clinical Oncology for presentation at a meeting starting May 31. Interim...
Google plans to charge for AI-powered search engine, FT reports
Google plans to charge for AI-powered search engine, FT reports
Apr 3, 2024
April 3 (Reuters) - Alphabet's Google is considering charging for premium features on its generative AI-powered search engine, the Financial Times reported on Wednesday, citing people familiar with the plan. The tech giant is looking at a variety of options, including incorporating AI-powered search features to its premium subscription services, which already provide access to its new Gemini AI assistant...
Elliott's Cohn says Etsy offers significant, multi-year upside for investors
Elliott's Cohn says Etsy offers significant, multi-year upside for investors
Apr 3, 2024
NEW YORK (Reuters) - Elliott Investment Management's managing director Jesse Cohn said on Wednesday he believes e-commerce platform Etsy ( ETSY ) will generate significant, multi-year upside. Elliott, one of the world's most prominent investors, has a 13% economic stake in Etsy ( ETSY ), including both common shares and swaps, a person familiar with the matter told Reuters in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved